With Chronic Kidney Disease (CKD) on the rise, and its clear relationship to unmanaged blood sugar and blood pressure unquestioned, virgin coconut oil is proving a valuable addition to the fight with ameliorate kidney function parameters in suffers of CKD and can even be protective for those at risk for the disease. Lowering your risk for kidney dysfunction rests largely on lifestyle changes, but for change to occur in something so entrenched as an individual’s lifestyle, there is a need for impetus, and despite the fact that over 37 million people in the US alone are estimated to have CKD, many of those are completely unaware of the slippery slope they are currently on or headed towards. It’s interesting that virgin coconut oil, which is often a prominent part of a healthy ketogenic diet, also shows promise in studies as a potential therapy in the treatment and prevention of kidney dysfunction. Perhaps the only thing standing in the way of discovering the full benefits of virgin coconut oil in the treatment of chronic kidney disease and fully embracing it, is our society's ingrained acceptance of long held and poorly supported nutritional doctrine. Luckily in the cases of kidney function and diabetes, science is confirming that there is hope to be found in change… and that a couple of tablespoons of virgin coconut oil consumed daily may be just the place to start.
The Health Benefits of Topical Virgin Coconut Oil for Preterm Infants – Studies Show Why You want to Massage Your Newborn Baby with Coconut Oil
Most of us who have reached maturity take our body's largest organ at face value, spending a staggering $300 billion on anti-aging globally and approximately $400 million U.S. dollars yearly on over-the counter acne solutions to put on a pretty face. But for the newest and most vulnerable among us, preterm and full-term infants, healthy skin is critical to their very survival, and here is where researchers think virgin coconut oil may be a major contributor in the fight to lower preterm infant mortality. Complications arising from preterm births are the leading cause of death globally for children under the age of five, according to the World Health Organization.
Repatha is a new cholesterol-lowering medication that works differently from statins. It is part of an expensive class of medications that currently costs about $14,000 per year. When Repatha first came out I predicted that this class of drugs would (similarly to statins) fail and, furthermore, cause too many adverse effects. When we reviewed the article, we concluded Repatha was not very effective as it failed to help nearly 98% who took it. As we were about to finish our discussion, I said let’s look at the adverse effects from this drug. Adverse side effects were encountered by 77.4% of those treated with both Repatha and the placebo. As for serious side effects, 24.8% of the Repatha group and 24.7% of the placebo group suffered a serious adverse effect. We were both stunned. How could a therapy have such a high rate of adverse effects, especially serious adverse effects? And, how could a placebo have such a high rate of adverse and serious adverse events?
Study: Coconut Oil a Healthy Saturated Fat – But the FDA Prohibits the use of “Healthy” in Describing Coconut Oil
Recently we covered a study published in the journal Clinical Nutrition which compared peanut oil consumption with coconut oil consumption among healthy men in India, where those who consumed coconut oil had better health outcomes in terms of heart disease and diabetes. (See: Coconut oil consumption improves fat-free mass, plasma HDL-cholesterol and insulin sensitivity in healthy men with normal BMI compared to peanut oil.) A researcher at The University of Edinburgh Medical School wrote a Letter to the Editor of Clinical Nutrition commenting on this study, criticizing current government nutritional guidelines regarding saturated dietary fat restrictions. "The cross-over study by Korrapati et al. detailed the potential cardioprotective effect of coconut oil, and I would like to thank the authors for their insight. Whilst the sample size was small, it was well-designed to investigate its primary end-points. This study is particularly topical as, despite removal of the maximum dietary fat intake restriction from guidelines, a major resistance against saturated fats remains." Setting aside the issue of whether or not saturated fats should be restricted at all, given the abundance of contrary evidence in the medical literature, the Edinburgh Medical School researcher reported that such guidelines do not distinguish between different types of saturated fats. Saturated fats can be found in animal products, such as butter, as well as plant sources, such as coconuts and date palms. "The rise in high density lipoprotein cholesterol (HDL-c) with coconut oil consumption is certainly a compelling finding. Results from a recent and larger-scale randomised trial by Khaw et al. corroborate this... Evidence suggests that the saturated versus unsaturated distinction of fats is likely an oversimplification. Korrapati et al. should, therefore, be commended on their focus on the biological properties of coconut oil, particularly the medium chain triglyceride (MCT) dominated fatty acid profile, which may confer atheroprotective effects."
Want to flip a coin on your health? Researchers assessing the effectiveness of cholesterol-lowering statin drugs found that they didn’t work for 51% of the 165,000 patients studied (statins have to reduce LDL cholesterol levels by 40% after two years to be considered effective). We’ve reported previously about the many side effects and dangers of taking statins. We’ve also pointed out that conventional thinking supporting statins—lowering “bad” LDL cholesterol as a means of preventing cardiovascular disease—is outdated. With one in four Americans over the age of 40 taking a statin, there are a lot of people out there spending money on a dangerous drug that is not providing any benefit. Will doctors change their prescribing practices based on this information? It doesn’t seem so. Statins make tens of billions of dollars a year for the drug industry, and the market is growing. Statin use among adults over the age of 40 increased almost 80% between 2002 and 2013.
Headlines in the corporate-sponsored "mainstream" media recently warned the public about a new "mysterious infection" that is drug-resistant. As a recent NY Times Health Section article reported, there is allegedly a hospital cover-up of an emerging candida fungus, Candida or C. auris. It is the latest antimicrobial drug-resistant "super-bug" to emerge in hospitals and nursing homes. This time it's not about bacteria, it's a virulent form of candida. And while the corporate media, sponsored in a large degree by Big Pharma, will almost never report on natural solutions, there is hope for fighting fungal infections like Candida where drugs have failed. One of the most beneficial natural products that fights and kills strains of Candida, according to peer-reviewed research over the past several years, is coconut oil.
Research outside of the United States continues to show what the world is investigating and learning about coconut oil, while such information is censored in the U.S. corporate "mainstream" media since coconut oil presents a threat to Big Food and Big Pharma's financial interests. Recent studies confirm that coconut oil protects the heart, and also potentially protects other vital organs including the liver and kidneys of those suffering from diabetes. This research contradicts the propaganda against coconut oil by American organizations such as the American Heart Association which still promote the now failed theory of heart disease that blames saturated fats and cholesterol as causative factors in heart disease.
As has been reported numerous times here at Health Impact News for the past 6 years or so, the pharmaceutical industry has been desperate to find an Alzheimer's drug to market to an aging baby boomer population with ever increasing numbers of Alzheimer's Disease cases. And yet, billions of dollars have been invested in potential drugs only to see these drugs never make it out of the trial phase and come to market, because they do not significantly help Alzheimer's patients. Biogen and their partner Eisai are the latest pharmaceutical companies to throw in the towel regarding their Alzheimer's drug aducanumab, which has failed to make it out of phase 3 trials. Many drug researchers have now abandoned the theory of amyloid plaque accumulation in the brain as the causative factor of Alzheimer’s. Could aducanumab's failure be the last nail in the coffin for this theory, as natural approaches to Alzheimer's such as coconut oil and the ketogenic diet see more positive results?
Independently-sourced research challenges the idea that LDL (low-density lipoprotein) is the "bad cholesterol," and causes heart disease. However, the theory that LDL is "bad" persists in the mainstream media and with Big Pharma, mainly because they would lose billions of dollars in drugs and treatments to admit the theory lacks merit. The hypothesis of saturated fat creating artery-clogging cholesterol as the source of heart disease should be considered dead and incapable of resuscitating, based on the scientific evidence. But one still sees and hears fearful statements about lowering cholesterol and avoiding heart disease, mostly on mainstream media but even all too often on internet alternative media sources. Current research is showing LDL is not dangerous and it’s not an accurate marker for pending heart disease.
A new study out of Japan and published in the European Journal of Allergy and Clinical Immunology shows how switching the dietary oil of chow fed to mice from soybean oil to coconut oil reduced skin inflammation. The skin healing properties of coconut oil, especially virgin coconut oil, applied topically to the skin have been known for a long time. Even though coconut oil is sold as a dietary oil, people applying it topically are seeing tremendous results for their skin conditions such as acne, eczema, keratosis polaris, psoriasis, rosacea, and fungal infections. We have suspected for years that the reason people in tropical climates who eat their traditional diets which are high in the saturated fats of coconut oil had such beautiful skin, even though they are exposed to the sun to a greater degree than westerners, is because of the high amounts of coconut oil in their diet, which does not oxidize and cause free radical damage as polyunsaturated fats do. Skin cancer, for example, is almost unheard of in tropical climates like the Philippines, but common in western nations, even in colder climates with far less exposure to the sun. Researchers in Japan apparently wanted to test this theory of dietary coconut oil reducing allergic skin inflammation in the laboratory: "Coconut oil is used as a dietary oil worldwide, and its healthy effects are recognized by the fact that coconut oil is easy to digest, helps in weight management, increases healthy cholesterol and provides instant energy. Although topical application of coconut oil is known to reduce skin infection and inflammation, whether dietary coconut oil has any role in decreasing skin inflammation is unknown. In this study, we showed the impact of dietary coconut oil in allergic skin inflammation by using a mouse model of contact hypersensitivity (CHS)."